Literature DB >> 2338846

Modulation of the effect of 1-beta-D-arabinofuranosylcytosine based on changes of cytidine deaminase activity in HL60 cells.

J N Mejer1, B T Mortensen, I J Christensen.   

Abstract

The effect of changes in cytidine deaminase activity on the growth inhibitory effect of 1-beta-D-arabinofuranosylcytosine (Ara-C) has been investigated in the human promyelocytic cell line, HL60. 1,25 Dihydroxy vitamin D3 (vit. D3), which is an inducer of differentiation, caused an increase of cytidine deaminase in HL60 cells simultaneous with an inhibition of the effect of Ara-C. On the other hand, retinoic acid, which also induces differentiation had no influence on either the activity of cytidine deaminase or the effect of Ara-C. An atoxic inhibitor of cytidine deaminase tetrahydrouridine, THU, enhanced the effect of Ara-C. THU also enhanced the effect of Ara-C, even if the Ara-C effect was inhibited by deoxycytidine. These results show that it is possible to modulate the effect of Ara-C by changing the activity of cytidine deaminase. Furthermore, changes in the activity of cytidine deaminase and the effect on the Ara-C growth inhibition vary dependent on the differentiating inducer used.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2338846     DOI: 10.1007/bf03000487

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  17 in total

1.  Interaction of deoxycytidine and deoxycytidine analogs in normal and leukemic human myeloid progenitor cells.

Authors:  S Grant; K Bhalla; M Gleyzer
Journal:  Leuk Res       Date:  1986       Impact factor: 3.156

2.  Purification and properties of cytidine deaminase from normal and leukemic granulocytes.

Authors:  B A Chabner; D G Johns; C N Coleman; J C Drake; W H Evans
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

3.  Studies of the enzymatic deamination of cytosine arabinoside. I. Enzyme distribution and species specificity.

Authors:  G W Camiener; C G Smith
Journal:  Biochem Pharmacol       Date:  1965-10       Impact factor: 5.858

4.  Mammalian deoxynucleoside kinase. I. Deoxycytidine kinase: purification, properties, and kinetic studies with cytosine arabinoside.

Authors:  R L Momparler; G A Fischer
Journal:  J Biol Chem       Date:  1968-08-25       Impact factor: 5.157

5.  Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytes.

Authors:  C N Coleman; R G Stoller; J C Drake; B A Chabner
Journal:  Blood       Date:  1975-11       Impact factor: 22.113

6.  S1-phase cells of the leukemic cell cycle sensitive to 1-beta-D-arabinofuranosylcytosine at a high-dose level.

Authors:  L A Smets; J Homan-Blok
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

7.  Changes in the activities of cytidine deaminase during differentiation of HL60 cells induced by 1,25 dihydroxy D3.

Authors:  J Mejer; B T Mortensen
Journal:  Leuk Res       Date:  1988       Impact factor: 3.156

8.  Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity.

Authors:  K Bhalla; W MacLaughlin; J Cole; Z Arlin; M Baker; G Graham; S Grant
Journal:  Blood       Date:  1987-08       Impact factor: 22.113

9.  Cytosine arabinoside triphosphate production in human leukaemic myeloblasts: interactions with deoxycytidine.

Authors:  A L Harris; D G Grahame-Smith
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

10.  Effect of antimetabolites and thymidine blockage on the induction of differentiation of HL-60 cells by retinoic acid or 1 alpha,25-dihydroxyvitamin D3.

Authors:  H Ishikura; T Okazaki; T Mochizuki; Y Izumi; M Tashima; H Sawada; H Uchino
Journal:  Exp Hematol       Date:  1985-11       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.